REFERENCES
- Siewert-Delle, A.; Ljungman, S.; Andersson, O K.; Wilhelmsen, L. Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the primary prevention study in Göteborg, Sweden. Nephrol. Dial. Transplant. 1998, 13, 3084–3090. [PUBMED], [INFOTRIEVE], [CSA]
- Luft, F C. Hypertensive nephrosclerosis-a cause of end-stage renal disease? Nephrol. Dial. Transplant. 2000; 15: 1515–1517. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Perrone, R D.; Madias, N E.; Levey, A S. Serum creatinine as an index of renal function: new insights into old concepts. Clin. Chem. 1992, 38, 1933–1953. [PUBMED], [INFOTRIEVE]
- Dharnidharka, V R.; Kwon, C.; Stevens, G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am. J. Kidney Dis. 2002, 40 (2), 221–226. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Newman, D J.; Cystatin, C. Ann. Clin. Biochem. 2002, 39, 89–104. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Price, C P.; Finney, H. Developments in the assessment of glomerular filtration rate. Clin. Chim. Acta 2000, 297, 55–66. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Laterza, O F.; Price, C P.; Scott, M G. Cystatin C: An improved estimator of glomerular filtration rate. Clin. Chem. 2002, 48 (5), 699–707. [PUBMED], [INFOTRIEVE], [CSA]
- Kyhse-Andersen, J.; Schmidt, C.; Nordin, G.; Andersson, B.; Nilsson-Ehle, P.; Lindstrom, V.; Grubb, A.;. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin. Chem. 1994, 40, 1921–1926. [PUBMED], [INFOTRIEVE], [CSA]
- Finney, H.; Newman, D J.; Gruber, W.; Merle, P.; Price, C P. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin. Chem. 1997, 43, 1016–1022. [PUBMED], [INFOTRIEVE], [CSA]
- Pergande, M.; Jung, K. Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodies. Clin. Chem. 1993, 39, 1885–1890. [PUBMED], [INFOTRIEVE]
- Harmoinen, A P.; Kouri, T T.; Wirta, O R.; Lehtimaki, T J.; Rantalaiho, V.; Turjanmaa, V M.; Pasternack, A I.. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin. Nephrol. 1999, 52 (6), 363–370. [PUBMED], [INFOTRIEVE], [CSA]
- Risch, L.; Blumberg, A.; Huber, A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol. Dial. Transplant. 1999, 14, 1991–1996. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Le Bricon, T.; Thervet, E.; Froissart, M.; Benlakehal, M.; Bousquet, B.; Legendre, C.; Erlich, D. Plasma cystatin C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation. Clin. Chem. 2000, 46, 1206–1207. [PUBMED], [INFOTRIEVE], [CSA]
- Orlando, R.; Mussap, M.; Plebani, M.; Piccoli, P.; De Martin, S.; Floreani, M.; Padrini, R.; Palatini, P. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin. Chem. 2002, 48, 850–858. [PUBMED], [INFOTRIEVE], [CSA]
- Mangge, H.; Liebmann, P.; Tanil, H.; Herrmann, J.; Wagner, C.; Gallistl, S.; Schauenstein, K.; Erwa, W. Cystatin, an early indicator for incipient renal disease in rheumatoid arthritis. Clin. Chim. Acta 2000, 300, 195–202. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kazama, J J.; Kutsuwada, K.; Ataka, K.; Maruyama, H.; Gejyo, F. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron 2002, 91, 13–20. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Levey, A S.; Bosch, J P.; Lewis, J B.; Greene, T.; Rogers, N.; Roth, D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Annu. Intern. Med. 1999, 130, 461–470. [CSA]
- Cockcroft, D W.; Gault, M H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16, 31–41., [PUBMED], [INFOTRIEVE]
- Du Bois, D.; Du Bois, E F. A formula to estimate the approximate surface area if height and weight are known. Arch. Intern. Med. 1916, 17, 863–871.
- Zweig, M H.; Campbell, G. Receiver-operating characteristics (roc) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1999, 39, 561–577.
- Mussap, M.; Vestra, M D.; Fioretto, P.; Saller, A.; Varagnolo, M.; Nosadini, R.; Plebani, M. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int. 2002, 61 (4), 1453–1461. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Randers, E.; Erlandsen, E J.; Pedersen, O L.; Hasling, C.; Danielsen, H. Serum cystatin c as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin. Nephrol. 2000, 54(3), 203–209. [PUBMED], [INFOTRIEVE], [CSA]
- Coll, E.; Botey, A.; Alvarez, L.; Poch, E.; Quinto, L.; Saurina, A.; Vera, M.; Piera, C.; Darnell, A. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am. J. Kidney Dis. 2000; Jul, 36 (1), 29–34.
- Hoek, F J.; Kemperman, F A.W.; Krediet, R T. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol. Dial. Transplant. 2003, 18, 2024–2031. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Perlemoine, C.; Beauvieux, M C.; Rigalleau, V.; Baillet, L.;Barthes, N.; Derache, P.;Gin, H. Interest of cystatin C in screening diabetic patients for early impairment of renal function. Metabolism 2003, 52 (10), 1258–1264.
- Mussap, M.; Ruzzante, N.; Varagnolo, M.; Plebani, M. Quantitative automated particle-enhanced immunonephelometric assay for the routine measurement of human cystatin C. Clin. Chem. Lab. Med. 1998, 36 (11), 859–865. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Watanabe, S.; Okura, T.; Liu, J.; Miyoshi, K.; Fukuoka, T.; Hiwada, K.; Higaki, J. Serum cystatin C level is a marker of end-organ damage in patients with essential hypertension. Hypertens. Res. 2003; Nov, 26 (11), 895–899. [CROSSREF]
- Seco, M L.; Rus, A.; Sierra, M.; Caballero, M.; Borque, L. Determination of serum cystatin c in patients with essential hypertension. Nephron 1999, 81 (4), 446–447. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]